Activated T-lymphocytes (GC Pharma)

N/A

Report date: 2024/12/12 11:34:41

Base Information

Drug NameActivated T-lymphocytes (GC Pharma)
Drug Alias NameActivated T-lymphocytes (Green Cross Cell)Immuncell-LCGCC4002GCC-4002
ClassificationBiologics > Blood components
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPancreatic NeoplasmsLiver NeoplasmsCarcinoma, Hepatocellular +[4
Global Approved IndicationsLiver Neoplasms
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2007/08/01
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGC Biopharma Corp
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsLiver NeoplasmsRejection of liver transplantation
Inactive IndicationsPancreatic NeoplasmsCarcinoma, Hepatocellular

Other Information

ATC CodeB05AX
Related LinksN/A